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Background: Only one strain (the Czech CAPM-v351) of rabbit haemorrhagic disease virus (RHDV) has been released in
Australia and New Zealand to control pest populations of the European rabbit O. cuniculus. Antigenic variants of RHDV
known as RHDVa strains are reportedly replacing RHDV strains in other parts of the world, and Australia is currently
investigating the usefulness of RHDVa to complement rabbit biocontrol efforts in Australia and New Zealand. RHDV
efficiently kills adult rabbits but not rabbit kittens, which are more resistant to RHD the younger they are and which
may carry the virus without signs of disease for prolonged periods. These different infection patterns in young rabbits
may significantly influence RHDV epidemiology in the field and hence attempts to control rabbit numbers.
Methods: We quantified RHDV replication and shedding in 4–5 week old rabbits using quantitative real time PCR to
assess their potential to shape RHDV epidemiology by shedding and transmitting virus. We further compared RHDV-v351
with an antigenic variant strain of RHDVa in kittens that is currently being considered as a potential RHDV strain for future
release to improve rabbit biocontrol in Australia.
Results: Kittens were susceptible to infection with virus doses as low as 10 ID50. Virus growth, shedding and transmission
after RHDVa infection was found to be comparable or non-significantly lower compared to RHDV. Virus replication and
shedding was observed in all kittens infected, but was low in comparison to adult rabbits. Both viruses were shed and
transmitted to bystander rabbits. While blood titres indicated that 4–5 week old kittens mostly clear the infection even in
the absence of maternal antibodies, virus titres in liver, spleen and mesenteric lymph node were still high on day 5 post
infection.
Conclusions: Rabbit kittens are susceptible to infection with very low doses of RHDV, and can transmit virus before they
seroconvert. They may therefore play an important role in RHDV field epidemiology, in particular for virus transmission
within social groups during virus outbreaks.
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Rabbit haemorrhagic disease (RHD) was first described in
1984 and the infectious agent, Rabbit Haemorrhagic Dis-
ease Virus (RHDV) was later identified as a member of the
Caliciviridae family of non-enveloped, positive-strand
RNA viruses [1-3]. The virus is highly contagious and kills
up to 95% of infected wild and domestic adult European
rabbits (Oryctolagus cuniculus) causing high losses to wild* Correspondence: tanja.strive@csiro.au
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unless otherwise stated.and farmed rabbits [4-9]. Wild rabbits are an important
part of many European ecosystems as well as a popular tar-
get for recreational hunting. Domestic rabbits are farmed
worldwide for meat and fur [10]. However, in Australia, fol-
lowing the introduction of wild rabbits in 1859, they quickly
became and remain one of the worst introduced vertebrate
pest species, causing immense losses to the agricultural in-
dustries and having a devastating impact on Australia’s bio-
diversity [9-14].
In 1995, the Czech CAPM-v351 strain of RHDV (herein
referred to as RHDV-v351) was unintentionally released in
Australia while being evaluated as a biological control
agent for rabbits and subsequently deployed to controlal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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recent years rabbit populations have recovered [16] poten-
tially due to a combination of high levels of population
immunity to RHDV-v351 [17-19], rabbits developing gen-
etic resistance against the virus [20,21] and the presence
of a non-pathogenic rabbit calicivirus acting as an imper-
fect natural vaccine [22,23].
In an effort to complement rabbit control programs in
Australia, additional RHDV strains are currently being
evaluated to determine their usefulness for release in
addition to RHDV-v351. There are indications that mem-
bers of the RHDVa subgroup of RHDV, which are antigen-
ically distinct to classical RHDV strains like the v351
strain, are replacing the classical RHDV strains in both
farmed and wild rabbits in some Asian and European
countries [9,24-27]. RHDVa has so far not been described
in wild populations from the Iberian Peninsula [28-31].
It is very rare in French rabbit populations [32] but
common in Italy where it was mainly described in do-
mestic breeds [33]. Since this suggests that RHDVa
strains potentially have a competitive advantage over clas-
sical RHDV in the field they may be able to complement
existing biological rabbit control in Australia. A possible
explanation for the increased competitiveness of RHDVa
strains is their reported ability to cause fatal infections in
rabbits incompletely immunised with a standard RHDV
vaccine [34]. Hence, RHDVa strains might be able to par-
tially overcome immunity to classical RHDV strains in
field rabbits by avoiding antibodies to some key epitopes
[24]. It is further known that classical RHDV and RHDVa
strains have a slightly different specificity for histo-blood
group antigens, which may enable RHDVa strains to infect
rabbits that are naturally less prone to infection with clas-
sical RHDV strains [21,35]. RHDVa strains are hence cur-
rently being assessed in adult rabbits to examine their
potential to improve rabbit biocontrol in Australia (A.J.R.
unpublished).
To most reliably predict the outcome of the release of
an additional RHDV strain it is essential to consider as
many potential factors influencing RHDV epidemiology as
possible and the current knowledge suggests that rabbit
kittens could play an important role in RHDV epidemi-
ology. Firstly, kittens are innately more resistant to fatal
RHD than adult rabbits [36,37]. At four weeks of age this
protection is almost complete, and gradually wanes until
they are fully susceptible at approximately 10 weeks. Ma-
ternal antibodies can protect kittens from acquiring the
RHDV infection, and delay RHDV exposure in the young,
but are not responsible for the innate resistance to lethal
infection [38]. The protection can be completely reversed
by artificial immunosuppression, and differences in the in-
nate immune mechanisms of young rabbits have been sug-
gested as the underlying cause for this resistance [39].
Secondly, virus transmission from 2 week old kittens totheir dams has been observed, even though very limited
pathology and virus replication was detected in livers from
kittens 2–4 weeks of age via immunofluorescence detection
of virus protein [40,41]. Thirdly, RHDV genomes were de-
tected via polymerase chain reaction (PCR) in tissues of kit-
tens weeks after infection, and systemic and potentially
persistent RHDV infections of young rabbits have been sug-
gested [42], although reactivation of RHDV infection and
shedding of infectious virus has not been reported. Lastly,
kittens that survive RHDV infection develop antibodies that
confer protection from further infection and may become
part of an immune breeding population, impacting RHDV
epidemiology and rabbit biocontrol [8,38,42,43]. Despite
their obvious relevance for field epidemiology, to this date a
quantitative assessment of RHDV replication and shedding
of RHDV in kittens has not been carried out.
To examine the potential role of rabbit kittens in RHDV
epidemiology, we quantitatively monitored infection, sero-
conversion, replication and excretion of the RHDV-v351
biocontrol strain in kittens over time. To complement the
evaluation of RHDVa strains in adult rabbits, we further
compared the replication kinetics and the ability to spread
to bystander rabbits of RHDV-v351 and a candidate
RHDVa strain identified in 2008 in Inchaon, South Korea
[26]. While our results indicate that rabbit kittens may
play an important role in RHD epidemiology, no signifi-
cant differences in infection characteristics between the
current RHDV-v351 and the RHDVa strain in rabbit kit-
tens were detected.
Results
RHDV infection characteristics in rabbit kittens
To assess the dynamics of viremia and virus excretion of
the current Australian biocontrol strain RHDV-v351, we
followed the course of infection over time in five rabbit
kittens 4–5 weeks of age infected orally with 700 ID50 (as
titrated in adult rabbits, A. J. R. unpublished). We moni-
tored virus genome copy numbers in blood and rectal
swabs via reverse transcription real-time PCR (RT-qPCR).
Median virus genome copy numbers in blood samples
were mostly below the detection limit of the assay (16 ge-
nomes) and peaked at 1 day post infection (dpi) in three
of the five rabbits, and very little viremia was detectable in
these kittens 3 dpi and thereafter (Figure 1A). Virus gen-
ome copies in rectal swabs peaked between day 1 and 5
and subsequently declined with little virus detectable 10
and 14 dpi (a median of 173 genomes per swab) when kit-
tens were autopsied (Figure 1B). In contrast to the low
amounts of virus observed in blood samples at late time
points, we detected 350, 800, 14700 18700, 40100 genome
copies (average = 15,000) per mg liver at 14 dpi (data not
shown). Highest titres of IgM antibodies specific for
RHDV were detected at day 7, which slowly decreased
until the end of the experiment (day 14, Figure 1C).
Figure 1 RHDV replication and excretion in rabbit kittens, which survived and seroconverted. Rabbit kittens 4–5 weeks of age were
infected with 700 ID50 of RHDV-v351 as determined in adults and virus replication and shedding was monitored via real-time PCR analysis of virus
genome copy numbers in blood and swab samples taken at the indicated times post infection. A: Virus genome copy numbers per μl whole
blood and B: virus genome copy numbers per swab sample. The copy lowest copy numbers that could be accurately detected with the amount
of template used in the assay is indicated (SDL = safe detection limit). Serum IgM (C) and IgG titres (D) were determined in blood samples taken
at the indicated times after infection via ELISA as described previously [54,55].
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tres increased to day 14 post infection (Figure 1D). No
signs of disease were observed during the 14 days the kit-
tens were monitored.
To estimate to what extent we detect inoculum or
virus progeny due to a productive infection when measur-
ing genome copy numbers, we also inoculated five kittens
orally with heat-inactivated virus. Heat-inactivation has
been shown to best preserve genome copy numbers meas-
urable by RT-qPCR compared to chemical inactivation pro-
cedures [44,45]. RT-qPCR analysis showed a drop of 55% in
genome copy numbers in heat-inactivated virus stock com-
pared to untreated virus preparation (9×108 genome copies
per millilitre heat-inactivated stock, equivalent to 2000
ID50/ml). After inoculation of 1 ml heat-inactivated virus,
we measured only trace amounts of virus genomes in daily
blood samples (Figure 2A) and in autopsy samples taken at
5 dpi (liver, mesenteric lymph node, spleen, duodenum and
bile, data not shown). In contrast, rectal swabs did contain
detectable viral genomes with a median of up to 730genomes per swab between day 1 and 4 (Figure 2B). There-
fore, 100-fold higher median viral genome concentrations
per swab as measured for untreated virus (compare Figure 1B
to Figure 2B) between 1 to 7 dpi, very likely indicate RHDV
replication and do not reflect inoculated virus alone. All five
kittens inoculated with heat-inactivated virus were serologic-
ally negative for RHDV-specific IgM at 5 dpi, indicating that
virus replication had not occurred.
In contrast to all previous studies where very high doses
(usually >1500 ID50) of virus were used to infect kittens, we
next examined if kittens are also susceptible to infection
with a dose as low as 10 ID50 (titrated in adult rabbits).
Notably, of the five kittens inoculated, one kitten died at 3
dpi presenting typical RHD liver pathology (discoloured
liver, enlarged spleen) at autopsy. The remaining four kit-
tens did not show signs of disease and seroconverted, as in-
dicated by IgM titres ≥ 1:1280 at 5 dpi and IgG titres >
1:20000 at 14 dpi, demonstrating that kittens do not require
a substantially higher dose than adults to become product-
ively infected.
Figure 2 Virus genome copy numbers in samples from rabbit kittens inoculated with heat inactivated RHDV. Kittens were inoculated
with 1 ml heat-inactivated (hi) RHDV containing 9x10e8 genome copies (equivalent to 2000 ID50). Kittens were sampled daily until autopsied at
day 5. A: Virus genome copy numbers per μl blood; B: Genome copy numbers in rectal swab samples. SDL indicates the genome concentration
relative to 20 genome copies detected in the RT-qPCR reaction, which is considered the safe detection limit.
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with a potential RHDVa candidate for future release
To compare RHDV-v351 and the potential candidate
RHDVa strain, we infected six kittens with 700 ID50 of
RHDV and in parallel six kittens with a similar amount
of RHDVa (approximately 2000 ID50 as titrated in adult
rabbits). Low levels of replication were observed for the
RHDV-v351 strain, with peak genome copy numbers in
blood after 2 dpi (Figure 3A), except for one kitten that
showed a pronounced viremia until the end of the ex-
periment (day 5). RHDVa genome copy numbers of up
to 280 genome copies/μl blood were observed, but me-
dian genome concentrations were lower than observed
for RHDV (Figure 3B). Genome copy numbers in swab
samples were comparable at day 4 and 5 between RHDV
and RHDVa (Figure 3C, D). Concentrations of genome
copy numbers in mesenteric lymph node, spleen, liver,
duodenum and bile did not differ significantly in RHDV
and RHDVa infected kittens at autopsy, 5 dpi (Figure 3E),
indicating a similar tissue specificity. In line with the low
level of virus replication, we only saw signs of RHD at
autopsy in one RHDV infected kitten (RHDV 3–3) that
had a pale liver.
We repeated these experiments using a higher amount
of inoculum equalling 4,300 ID50 of RHDV (1.6×10
9 ge-
nomes) and 53,000 ID50 of RHDVa (4.7×10
10 genomes).
Inoculation of such high amounts of virus resulted in high
viral loads in the blood of two of six RHDV infected ani-
mals (2.2×105 and 6.8×105 genome copies/μl) at 2 dpi and
a third kitten had 2.8×104 genomes/μl blood at day 3.
While the amount of viral genomes mostly decreased in
blood samples towards later time points, one RHDVa in-
fected kitten showed increasing viremia from 3 dpi on-
wards, reaching 7×104 genomes/μl on day 5 (Figure 4A, B).
Viral genome numbers measured in rectal swabs revealed a
biphasic curve with a first peak between day one and twoand another one at day 4–5. Median RHDV genome copy
numbers in rectal swabs at day 4 to 5 pi were 2–7 times
higher compared to RHDVa (Figure 4C, D). Notably,
the >10 times higher dose of virus used to inoculate RHDVa
was not reflected in the genome copy numbers measured in
rectal swab samples. The amount of virus genomes detected
in tissues taken 5 dpi varied considerably between individ-
uals, with very high virus loads observed in the kittens that
also had high genome copy numbers in blood. Interestingly,
median genome copy numbers in duodenum and bile were
very similar between strains (Figure 4E). None of the kittens
showed clinical signs of RHD during this experiment, but at
autopsy clear evidence of RHD (discoloured liver, enlarged
spleen) was observed in two RHDV infected kittens (RHDV
4–3 and RHDV 4–4) and in kitten RHDVa 4–6, which still
showed increasing viremia at the time of autopsy. The
Korean RHDVa strain reached lower blood virus con-
centrations compared to RHDV, even when inoculated
at a much higher dose. No differences in rectal virus
excretion and tissue loads were obvious.
Comparative transmission studies of RHDV-v351
and RHDVa
In addition, we examined if transmission of virus to by-
stander kittens occurs, and if the two strains differ in their
transmissibility/infectivity, by group-housing one kitten
infected with RHDV and one with RHDVa with four unin-
fected bystanders. The experiment was carried out in trip-
licates. Only one of the 12 bystanders became infected
with the RHDV-v351 strain, indicated by 13,000 genome
copies per mg liver taken at autopsy, 5 days after being
housed with the infected kittens (data not shown).
In a second transmission study, two kittens infected with
the high dose of RHDV and two infected with RHDVa were
housed with four uninfected bystanders in one cage, 24 h
post infection. Virus replication in the infected animals was
Figure 3 RHDV and RHDVa replication, excretion and tissue distribution in rabbit kittens. Shown are virus genome copy numbers per μl
whole blood (A, B) or rectal swab (C, D) as measured via RT-qPCR in samples from RHDV (A, C) and RHDVa (B, D) infected kittens 4–5 weeks of
age at the indicated time points. SDL indicates the genome concentration relative to 20 genome copies detected in the RT-qPCR, which is
considered the safe detection limit. E: Virus loads in tissues of RHDV and RHDVa infected kittens, 5 dpi. The safe detection limit of our assay in
these tissues was 400 genome copies/mg on average (range 140–678 depending on the amount of tissue used for RNA extraction) or 20 genome
copies/μl bile.
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fected animals were euthanized at day 2 (n = 2) and day 4
(n = 2). Bystander rabbits were also monitored daily for
virus replication by collecting blood and rectal swabs, and
were euthanized at day 5 after their placement with the in-
fected littermates. Livers of all animals were collected at
autopsy for virus quantification. This experiment was alsocarried out in triplicate. Six of the 12 bystander rabbits ac-
quired an infection, shown by detectable RNA in swab,
blood and liver samples (Figure 5), demonstrating that
kittens can shed infectious virus that is transmitted to
littermates. Using PCR assays specific either for the
RHDV or RHDVa strain, we determined that four of the
six kittens that acquired an infection got infected with
Figure 4 RHDV and RHDVa replication, excretion and tissue distribution in rabbit kittens infected with a high dose of inoculum. Shown
are virus genome copy numbers per μl whole blood (A, B) or rectal swab (C, D) measured via RT-qPCR in samples taken from RHDV (A, C) and
RHDVa (B, D) infected kittens 4–5 weeks of age at the indicated time points. SDL indicates the genome concentration relative to 20 genome
copies detected in the RT-qPCR, which is considered the safe detection limit. E: Virus loads in tissues of RHDV and RHDVa infected kittens, 5 dpi.
The safe detection limit of our assay in these tissues was 40 genome copies/mg on average (range: 35–71 depending on the amount of tissue
the RNA was extracted from) or 12 genome copies/μl bile.
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of the RHDVa infected bystander kittens was also posi-
tive for RHDV (with < 10% of detected genome copies
being RHDV), indicating a mixed infection. It is worth
noting that 3 of the 4 RHDV positive bystanders came
from the same cage in which one kitten initially inocu-
lated with RHDV (RHDV 5–5), was found dead at 4 dpiwith very high amounts of viral genomes in swab, blood
and liver samples (Figure 5C, F, I). One of the three by-
standers (BS 5–11) in that cage also was found dead
with clear signs of RHD at autopsy and another kitten
(BS 5–10) had a high viremia five days after being
placed with the infected kittens and a very pale liver at
autopsy.
Figure 5 Infectious RHDV and RHDVa particles are shed from infected kittens and virus is transmitted to littermates. Two kittens
infected with either RHDV or RHDVa (high dose of inoculum) were placed with four uninfected littermates (bystanders, BS). Each column
represents one replicate of the experiment done in triplicates (trial 1: A,D,G; trial 2: B,E,H; trial 3: C,F,I). All kittens were monitored for virus
replication via blood and swab samples. Experimentally infected kittens were euthanased at 2 or 4 dpi, and bystanders six days after the trial
started. Upper panel: Virus shed over time by kittens infected with RHDV (blue) or RHDVa (red) and bystanders (black); Middle panel: Virus
concentration in blood samples of infected and bystander kittens (colour code as above). Lower panel: Virus load in livers of infected kittens and
bystanders at the time of autopsy, 2 and 4 dpi. Blue and red bars indicate RHDV and RHDVa genome copy numbers, respectively. SDL (A-F)
indicates the genome concentration relative to 20 genome copies detected in the RT-qPCR, which is considered the safe detection limit The
average safe detection limit in the liver tissues was 46 genomes/mg (range 30 – 82). Identification and quantification of the virus that infected
the bystanders was done by analysing the liver RNA extracts using a RT-qPCR specific for either RHDV or RHDVa (G-I). In case of one bystander
(BS 5–3, see G) both PCRs were positive, and a determination of RHDV genome copy numbers with the specific RT-qPCR assay indicated that
most (>90 %) of the genomes in its liver were RHDVa genomes (pink bar). Kitten RHDVa 5–6 did not get infected. *indicates kittens that were
found dead, both in the morning of days when autopsies were scheduled.
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tible to productive RHDV infection after oral inoculation.
RHDV infections in kittens were mostly apathogenic, with
little virus detectable in blood and tissues. Virus clearance
started at day 3 post infection, at the same time as IgM be-
came detectable. Only a few kittens developed high virus
loads and these also displayed signs of disease at autopsy
or died. Differences between the RHDV and RHDVa strain
were minor and not statistically significant with slightly
lower amounts of virus in the blood and less pathogenicity
detected for the RHDVa strain.
Discussion
Our results verify and add to the existing knowledge about
RHD in rabbit kittens: It has been shown that kittens can
be infected with RHDV if high amounts of virus (at least
1500 LD50) are inoculated intra muscularly or orally[38,40,41,46]. We demonstrate here productive infection
and seroconversion in 4 of 5 kittens (and one death) after
oral inoculation with 10 ID50, which is at least 150-times
less than what had been previously used to inoculate kit-
tens. The infectious dose for domestic seronegative rabbit
kittens therefore does not appear to be substantially higher
than for adult rabbits.
Virus amounts observed in livers of kittens autopsied at
5 dpi were approximately 1000-times lower compared to
adult rabbits that succumbed to infection ([47] and A.J.R.,
unpublished). The only exceptions were the eight out of
82 kittens exposed to the virus that died or showed signs
of disease at autopsy and may have died if the trial had
been continued. In kittens showing signs of disease, virus
loads were higher in liver and blood compared to kittens
with subclinical infections, which demonstrates directly
for the first time that pathogenicity of RHDV in rabbit
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more, our results indicate that in the small proportion of
4–5 week old rabbits that succumb to infection [38],
RHDV does not cause a prolonged disease or a gradual in-
crease of replication levels, but rather shows the same
characteristics as observed in adult rabbits. Despite the
low levels of replication, a strong adaptive immune re-
sponse was induced in all kittens tested for seroconversion
(5 of 5 kittens infected with 700 ID50 RHDV, shown in
Figure 1, and 4 of 4 as mentioned in the text infected with
10 ID50 of RHDV).
While virus RNA can still be detected in tissues of con-
valescent rabbits months after primary infection, this RNA
has never been demonstrated to be infectious [48,49], and
no reactivation of RHDV infections has been described. In
our study the amount of virus shed from kittens declined
with the onset of the adaptive immune response (Figure 1)
and the period of virus excretion was limited to a few days
after infection in surviving disease-free kittens. The likeli-
hood that prolonged RHDV infection in kittens may rep-
resent a reservoir for RHDV between outbreaks [42,46]
hence appears low. This is also supported by a recent gen-
etic study indicating that subsequent annual outbreaks at
one site are caused by genetically different RHDV strains
[50]. Nevertheless, our results show that kittens can shed
virus in sufficient amounts to potentially transmit RHDV
in the field, and may therefore play an important role for
transmitting the virus during an outbreak, in particular
within warren systems. However, the experimental condi-
tions mean that we cannot completely exclude the possi-
bility that some of the virus that infected the bystanders in
the transmission experiment was from inoculum shed by
the orally infected kittens and not virus progeny resulting
from productive infection.
An RHDVa strain with different infection characteristics
compared to RHDV-v351 in rabbit kittens could signifi-
cantly alter RHD epidemiology and the effectiveness of
Australian viral rabbit control efforts, e.g. by causing more
kittens to seroconvert or by being spread more effectively
due to increased replication in kittens. As a case in point, a
recently described RHDV variant termed RHDV2 appears
to be replacing other field strains of RHDV and RHDVa in
wild rabbit populations and rabbitries in Europe [29,51-53].
Notably, this new variant has been reported to kill young
rabbits more effectively, further pointing to an important
role kittens may play in RHDV epidemiology and highlight-
ing the need to study virus isolates considered for release as
additional rabbit control agents in Australia in young rab-
bits. Hence, we also examined the infection characteristics
of an RHDVa strain and showed that fewer kittens devel-
oped high virus loads and signs of disease after infection
and there were no fatalities compared to infection with
RHDV. As the amount of RHDV- v351 and RHDVa used
for infection in this trial was not identical, a directcomparison is difficult to make. However, lower genome
copy numbers in blood and tissues as well as less virus ex-
cretion and transmission were observed even when 12-
times higher amounts of RHDVa compared to RHDV were
inoculated into kittens (Figures 4 and 5), although this dif-
ference was not statistically significant. This suggests that
the RHDVa strain might be less virulent in New Zealand
White rabbit kittens than the current RHDV biocontrol
strain, independent of the amount of virus inoculated.
Previous studies have shown that wild rabbits have an
increased level of resistance to infection with RHDV-
v351 [20]. It is feasible that the replication kinetics of
RHDVa also differs in wild rabbits – this will need to be
assessed experimentally in future studies. However, rep-
lication and transmission properties in kittens alone are
not likely to be the sole determining factor for a putative
additional biocontrol strain to be considered for release
in Australia. More importantly, virulence parameters in
adult rabbits (wild and domestic) such as efficient repli-
cation, high mortality rates and infectivity/transmissibil-
ity, as well as the ability to partially overcome antibodies
to RHDV and the benign calicivirus RCV-A1 will be key
to defining a suitable additional RHDV strain able to
complement rabbit biocontrol in Australia. A number of
candidates are currently being investigated.
Materials and methods
Virus strains and preparations
The inoculum of the Czech CAPM-v351 RHDV strain was
a commercially available virus preparation used in rabbit
biocontrol (RHDV batch 1C, produced at the Elizabeth
Macarthur Agricultural Institute (EMAI); the RHDVa
inoculum was clarified 10% liver homogenate in PBS of an
adult rabbit infected with the RHDVa strain described as
08Q712-1 [26]. Heat-inactivated RHDV stock was gener-
ated by incubating the virus preparation in 2 ml screw cap
tubes for 180 s at 85°C in a water bath to ensure a drop in
infectious virus of more than 99.9% [44,45]. RT-qPCR ana-
lysis of the heat inactivated RHDV suspension indicated a
drop in detectable genomes to 45% compared to untreated
virus suspension. Virus amounts inoculated into rabbits are
given as multiples of ID50 determined in adult rabbits (older
than 12 weeks). The RHDV and RHDVa preparations used
had comparable ID50 to genome copy ratios.
Rabbit trials
Animal trials were carried out according to Australian
Animal Research Acts and the Australian Code of Practice
for the care and use of animals for scientific purposes at
the EMAI in Australian Quarantine Inspection Service
approved facilities and at the CSIRO Black Mountain site.
All procedures were approved by the respective animal
ethics committees (M11/09 and M10-09, as well as
CESAEC 11–01 and DOMRAB-12). Rabbit kittens were
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vaccinated against RHDV, and one vaccinated male rabbit
in the CSIRO Ecosystem Sciences rabbit breeding colony.
The colony is routinely monitored and confirmed free
of the benign calicivirus RCV-A1 [23]. Kittens were
weaned at 28 days of age and had ad libitum access to
food (commercial rabbit pellets and autoclaved lucerne
hay) and water. Rabbits from the same litter were
group-housed during the experiments whenever pos-
sible. At 31 days of age (+/−1 d), kittens were infected
with RHDV or RHDVa and monitored daily. Blood sam-
ples were taken from the marginal ear vein (50 μl) and
pipetted into 50 μl distilled water to lyse blood cells.
Swab samples were taken with the copped end of Swis-
spers® cosmetic cotton tips. Excess faecal material was
stripped, before the swabs were eluted in 400 μl PBS. To
assess seroconversion of kittens infected with RHDV,
additional volumes of blood were collected into Vacu-
ettes® (Greiner Bio-One, with clot activator) and the
serological status monitored via ELISA (see below). Tis-
sue samples including mesenteric lymph node, spleen,
liver and duodenum, as well as bile, were collected dur-
ing autopsy after euthanasia via intracardiac barbiturate
injection following anaesthesia with Zoletil (50 mg/kg).
Samples were frozen at −80°C until further processed.
To compare RHDV and RHDVa strains, equal num-
bers of kittens from different litters were infected with
one of the viruses and littermates infected with the same
virus were housed together. Transmission experiments
were done by placing infected kittens with uninfected lit-
termates 24 hrs post inoculation, to reduce the chance
of infecting bystanders due to spillage of inoculum.
RNA extractions
RNA isolation was done using the Qiagen RNeasy (tis-
sues) and Invitrogen’s PureLink Viral RNA/DNA kit
(swab, blood and bile) from samples obtained during the
experiments with RHDV alone (Figures 1 and 2). RNA
was extracted from 50–200 μl of swab eluates, 50 μl
supernatant of the 1:1 blood-water mixtures after centri-
fugation for 10 min at 13000 g−1, 50 μl of bile, and 50 μl
of approximately 50 mg tissue lysed in 1 ml PBS via bead
beating (glass beads, 50 sec, Mini Bead beater, BioSpec).
For the comparative experiments and transmission stud-
ies (Figures 3, 4 and 5), total nucleic acids were extracted
from blood, rectal swabs and tissue homogenates using
the MagMAX-96 RNA Isolation Kit (Cat AM 1836–5,
Ambion, Texas, USA) on a KingFisher™ 96 magnetic par-
ticle handling system (Thermo Fisher Scientific, Finland).
Lysis-binding buffer (130–200 μl) was placed into a deep
well plate (Cat. No. 97040450, Thermo Scientific) followed
by sample (50 μl blood, bile and tissue homogenate, up to
200 μl swab eluate). The addition of magnetic beads, wash-
ing and elution of nucleic acid followed the manufacturer’sinstructions and the manufacturer supplied extraction pro-
grams ‘AM1836 DW std’ or ‘AM1836 DW 200v2’ for the
KingFisher™ 96 system (for 50 μl or 200 μl sample volume,
respectively). Nucleic acids were eluted in 30 or 50 μl H2O.
Tissue homogenisation was done as described above but
using Zirconia beads and a mini bead-beater (Biospec Prod-
ucts, Bartesville, USA).
Reverse transcription real-time PCR analysis
Standards for reverse transcription-real time PCR were
generated from RHDV and RHDVa RNA, using primer 5′
CTC GCC AGT GGT ATT ATA AAT CTT AAC AC-3′
for reverse transcription. The cDNA was amplified using
the same primer and 5′ GAC AAC AGG TAA TAC GAC
TCA CTA TAG GGA CTG CAA CCA GTA CC-3′,
which contains a T7-promoter. The PCR products were
purified and used for in vitro transcription (Promega,
Riboprobe kit) according to the manufacturer’s instruc-
tions. RT-qPCR was done using the One-step rt-PCR kit
with Sybr Green (Bio-Rad) on a Bio-Rad CFX96/C1000
Thermal cycler platform, using the following primers: 5′-
ACC CAG TAC GGC ACR GGC TCC CAA CCA C-3′
and 5′-CTA TCT CCA TGA AAC CAG ATG CAA AGG
T-3′ [47], which amplified the respective RHDV and
RHDVa fragments with comparable efficiency. Strain-
specific PCR analysis was carried out as described above
using 5′-GTT GTA TTC GGG CAA CCG GAA G-3′/ 5′-
CTA TGG AAC ACA AGC AAA CAT CAC CA-3′
(RHDV) and 5′-GGT TGT TTA TGG TGC CTGTAA
AGC A-3′/5′-GCA CAA ATT ACC TTG TCC CAA
AAG TTT-3′ (RHDVa).
RT-qPCR assays started with 10 min at 50°C for reverse
transcription, followed by 5 min denaturation at 95°C.
Cycle conditions were 10 s at 95°C denaturation, 40 s at
63°C annealing and elongation and 10 s at 78°C data ac-
quisition repeated 41 times and followed by a melt curve
analysis (65-95°C, 0.5°C increments, 5 s per increment).
Reactions with a total reaction volume of 10 μl including
1 μl of the extracted RNA were set-up manually in tripli-
cates in 96-well plates (Bio-Rad, Multiplate™) on ice and
the plates sealed with Microseal B Adhesive Sealer (Bio-
Rad). For cycler control, data analysis and evaluation the
CFX manager 2.0 software (Bio-Rad) was used. The assay
has a detection limit of 20 genomes/reaction [47] and the
respective threshold for genome copy numbers per mg tis-
sue, swab or μl blood are indicated by a dotted line in the
figures or the figure captions. Samples that gave a negative
result in the RT-qPCR analysis were set to 1 genome copy
for subsequent analysis and illustration.
Titration of RHDV-specific IgG and IgM in rabbit sera
Serum was separated from blood collected in evacuated
tubes (Vacuettes®, Greiner Bio-One) from the marginal
ear vein (or from the heart of the anaesthetised animals
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IgG and IgM specific ELISA [54] according to the pub-
lished protocol [55].
Data analysis tools
Testing for significant differences between the RHDV and
the RHDVa strain was done using two-tailed student t-
tests or Wilcoxon matched-pairs signed ranked tests (if
normal distribution could not be assumed) and GraphPad
Prism 6. The most significant difference between the
RHDV and RHDVa strain detected was p = 0.065 (exact p-
value) for median virus genome copy numbers in blood
samples after high dose infection (Figure 4).
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